Compass Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting

Compass Therapeutics, Inc.

Philip J. Ferneau re-elected with 57.0M votes for, 8.5M withheld; Carl L. Gordon with 55.5M for, 10.0M withheld.
Ratification of CohnReznick LLP as auditor for FY 2022 passed with 82.3M for, 65,654 against, 5,702 abstain.
No other proposals or material changes disclosed at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.